Alternative spliced variants of the alpha-methylacyl-CoA racemase gene and their expression in prostate cancer

Gene

Volumn 327, Issue 1, 2004, Pages 89-98

  Mubiru, James N ^a   Shen Ong, Grace L ^b   Valente, Anthony J ^a   Troyer, Dean A ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b NATIONAL EYE INSTITUTE   (United States)

Author keywords

Alternative splicing; Fumarate hydratase; Mitochondria; Peroxisome; Prostate cancer; Racemase

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; ACYL COENZYME A; FUMARATE HYDRATASE; GENE PRODUCT; MITOCHONDRIAL ENZYME; POLYPEPTIDE; RACEMASE; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CANCER TISSUE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EXON; GENE OVEREXPRESSION; GENETIC CODE; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOLECULAR WEIGHT; NUCLEOTIDE SEQUENCE; PEROXISOME; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY;

EID: 0442307867     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2003.11.009     Document Type: Article

References (23)

1. Amery L., Fransen M., Nys K.D., Mannaerts G.P., Veldhoven P.P.V. Mitochondrial and peroxisomal targeting of 2-methyl-CoA racemase in humans. Lipid Res. 41:2000;1752-1759.
2. Dhanasekaran S.M., Barrette T.R., Ghosh D., Shah R., Varambally S., Kurachi K., Pienta K.J., Rubin M.A., Chinnaiyan A.M. Delineation of prognostic biomarkers in prostate cancer. Nature. 412:2001;822-826.
3. Don H.R., Cox P.T., Wainright B.J., Baker K., Mattick J.S. 'Touchdown' PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res. 19:1991;4008.
4. Ferdinandusse S., Denis S., IJlst L., Dacremont G., Waterham H.R., Wanders R.J.A. Subcellular localization and physiological role of α-methylacyl-CoA racemase. J. Lipid Res. 41:2000;1890-1896.
5. Ferdinandusse S., Denis S., Clayton P.T., Graham A., Rees J.E., Allen J.T., McLean B.N., Brown A.Y., Vreken P., Waterham H.R., Wanders J.A. Mutations in the gene encoding peroxisomal α-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy. Nat. Genet. 24:2000;188-191.
6. Jiang Z., Woda B.A., Rock K.L., Xu Y., Savas L., Khan A., Pihan G., Cai F., Bacook J.S., Rathanaswami P., Reed S.G., Xu J., Fanger G.R. P504S, a new molecular marker for the detection of prostate carcinoma. Am. J. Surg. Pathol. 25:2001;1397-1404.
7. Kotti T.J., Savolainen K., Helander H.M., Yagi A., Novikov D.K., Kalkkinen N., Conzelmann E., Hiltunen J.K., Schmitz W. In mouse, α-methylacyl-CoA racemase, the same gene product is simultaneously located in mitochondria and peroxisomes. J. Biol. Chem. 275:2000;20887-20895.
8. Leav I., McNeal J.E., Ho S.M., Jiang Z. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone. Hum. Pathol. 34:2003;228-233.
9. Luo J., Duggan D.J., Chen Y., Sauvageot J., Ewing C.M., Bittner M.L., Trent J.M., Isaacs W.B. Human prostate cancer and benign prostatic hyperplasia: molecular dissection by expression profiling. Cancer Res. 61:2001;4683-4688.
10. Magee J.A., Araki T., Patil S., Ehrig T., True L., Humphrey P.A., Catalona W.J., Watson M.A., Milbrandt J. Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res. 61:2001;5692-5696.
11. Reichel C., Brugger C.R., Bang H., Geisslinger G., Brune K. Molecular cloning and expression of 2-arylproprionyl-coenzyme A epimerase: a key enzyme in the inversion metabolism of ibuprofen. Mol. Pharmacol. 51:1997;576-582.
12. Ron D., Dressler H. pGSTag - a versatile bacterial expression plasmid for enzymatic labeling of recombinant proteins. BioTechniques. 13:1992;866-869.
13. Rubin M.A., Zhou M., Dhanasekaran S.M., Varambally S., Barrette T.R., Sanda M.G., Pienta K.J., Ghosh D., Chinnaiyan A.M. α-Methylacyl coenzyme a racemase as a tissue biomarker for prostate cancer. JAMA. 287:2000;1662-1670.
14. Schmitz W., Albers C., Fingerhut R., Conzelmann E. Purification and characterization of an α-methylacyl-CoA racemase from human liver. Eur. J. Biochem. 231:1995;815-822.
15. Schmitz W., Helander H.M., Hiltunen J.K., Conzelmann E. Molecular cloning of cDNA species for rat and mouse liver α-methylacyl-CoA racemases. Biochem. J. 326:1997;883-889.
16. Shen-Ong G.L., Feng Y., Troyer D.A. Expression profiling identifies a novel α-methylacyl-CoA racemase exon with fumarate hydratase homology. Cancer Res. 63:2003;3296-3301.
17. Stephenson R.A. Prostate cancer trends in the area of prostate-specific antigen. An update of incidence, mortality, and clinical factors from the SEER database. Urol. Clin. North Am. 29:2002;173-181.
18. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTALW: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 11:1994;4673-4680.
19. Verhoeven N.M., Roe D.S., Kok R.M., Wanders R.J.A., Jakobs C., Roe C.R. Phytanic acid and pristanic acid are oxidized by sequential peroxisomal and mitochondrial reactions in cultured fibroblasts. J. Lipid Res. 39:1998;66-74.
20. Weaver T.M., Levitt D.G., Donnelly M.I., Wilkens Stevens P.P., Banaszak L.J. The multisubunit active site of fumarase C from Escherichia coli. Nat. Struct. Biol. 2:1995;654-662.
21. Welsh J.B., Sapinoso L.M., Su A.I., Kern S.G., Wang-Rodriguez J., Moskaluk C.A., Frierson H.F. Jr., Hampton G.M. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 61:2001;5974-5978.
22. Xu J., Stolk J.A., Zhang X., Silva S.J., Houghton R.L., Matsumura M., Vedvick T.S., Leslie K.B., Badaro R., Reed S. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res. 60:2000;1677-1682.
23. Zhou M., Chinnaiyan A.M., Kleer C.G., Lucas P.C., Rubin M.A. Alpha-methylacyl CoA racemase. A novel tumor marker over-expressed in several human cancers and their precursor lesions. Am. J. Surg. Pathol. 26:2002;926-931.